Summit Securities Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.01K | Buy |
+33
| New | +$5.01K | ﹤0.01% | 847 |
|
|
2023
Q3 | – | Sell |
-68
| Closed | -$14K | – | 486 |
|
|
2023
Q2 | $14K | Sell |
68
-31
| -31% | -$6.38K | ﹤0.01% | 590 |
|
|
2023
Q1 | $20K | Sell |
99
-1,336
| -93% | -$270K | ﹤0.01% | 492 |
|
|
2022
Q4 | $313K | Buy |
+1,435
| New | +$313K | 0.01% | 206 |
|
|
2022
Q3 | – | Sell |
-107
| Closed | -$23K | – | 743 |
|
|
2022
Q2 | $23K | Buy |
107
+86
| +410% | +$18.5K | ﹤0.01% | 548 |
|
|
2022
Q1 | $6K | Buy |
+21
| New | +$6K | ﹤0.01% | 688 |
|